|
Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 344,35 CHF | +1,01% |
|
+1,89% | +5,00% |
| 04:19 | BGI en Roche lanceren diagnostische tests voor Alzheimer in China | RE |
| 13/01 | CEO van Roche Pharma over Obesitasmiddelen van het Bedrijf | MT |
Belangrijkste concurrenten
Toevoegen aan een lijst 0 geselecteerde | Verschil (%) | Varia. 5d. | Evolutie 1 maand | Evolutie 3 maanden | Var. 1 jan | Varia. 1j. | Varia. 3j. | Varia. 5j. | Varia. 10j. | Kap.($) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1,01% | +1,89% | +7,05% | +20,41% | +5,00% | +30,83% | +16,97% | +10,43% | +31,28% | 363 mld. | |
| -0,35% | +1,24% | +4,83% | +31,46% | +0,23% | +35,07% | +197,88% | +480,70% | +1.258,37% | 964 mld. | |
| +1,87% | +4,33% | +0,98% | +11,92% | +3,24% | +47,89% | +23,19% | +35,32% | +120,21% | 515 mld. | |
| +0,32% | -1,42% | -1,15% | -4,15% | -3,39% | +24,90% | +43,72% | +96,31% | +331,32% | 390 mld. | |
| +2,51% | +1,11% | +5,66% | +12,91% | +4,29% | +35,30% | +23,18% | +90,26% | +232,69% | 292 mld. | |
| +1,49% | +1,57% | +7,59% | +10,90% | +5,27% | +28,04% | +33,82% | +38,15% | +39,69% | 272 mld. | |
| -0,85% | -0,56% | +7,94% | +26,32% | +2,85% | +7,21% | -3,55% | +31,48% | +113,70% | 269 mld. | |
| +0,07% | +4,69% | +21,24% | +6,36% | +17,94% | -35,24% | -19,47% | +75,46% | +104,81% | 265 mld. | |
| -0,38% | -1,78% | +2,06% | +10,91% | -0,92% | +20,03% | +19,35% | +36,41% | +122,95% | 175 mld. | |
| -0,69% | +0,33% | +1,13% | +3,00% | -0,80% | +35,38% | +41,14% | +97,86% | +31,58% | 151 mld. | |
| -0,47% | -1,10% | -2,71% | +1,70% | +1,00% | -6,16% | -47,44% | -31,77% | -17,19% | 143 mld. | |
| +1,44% | -1,32% | +1,32% | -2,72% | -1,28% | -12,42% | -11,09% | +0,85% | +11,41% | 114 mld. | |
| -1,29% | -2,93% | +0,58% | +11,61% | +0,29% | +9,99% | +51,08% | +100,21% | +371,80% | 115 mld. | |
| +0,27% | +2,76% | +6,70% | +28,43% | +3,67% | +1,01% | -22,88% | -13,61% | -8,75% | 114 mld. | |
| +0,39% | -1,77% | +1,87% | +14,07% | +2,38% | +44,40% | +30,06% | +7,24% | +8,24% | 100 mld. | |
| +1,08% | +1,52% | +0,16% | +21,83% | +3,46% | +25,41% | +164,35% | +46,98% | +572,38% | 87,23 mld. | |
| -.--% | +1,73% | - | - | - | - | - | - | - | 63,66 mld. | |
| +1,05% | +2,32% | +1,96% | -3,67% | +8,31% | +50,71% | +64,30% | -31,22% | +374,99% | 61,48 mld. | |
| +2,59% | +4,00% | +14,93% | +21,81% | +6,51% | +24,97% | +25,52% | +39,57% | -7,36% | 49,82 mld. | |
| -0,26% | -8,97% | -6,94% | -20,43% | -6,96% | +43,25% | +57,08% | +116,44% | +391,71% | 48,88 mld. | |
| Gemiddelde | +0,56% | +0,22% | +3,96% | +10,67% | +2,69% | +21,61% | +36,17% | +64,58% | +214,94% | 227,68 mld. | |
| Gewogen gemiddelde per kap. | +0,49% | +1,07% | +4,59% | +15,10% | +2,63% | +24,69% | +59,26% | +139,34% | +381,48% |
Kies jouw editie
Alle financiële informatie op nationaal niveau
